These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral Modified Drug Release Solid Dosage Form with Special Reference to Design; An Overview. Murugesan S; Gowramma B; Lakshmanan K; Reddy Karri VVS; Radhakrishnan A Curr Drug Res Rev; 2020; 12(1):16-25. PubMed ID: 31755398 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in oral pulsatile drug delivery. Kalantzi LE; Karavas E; Koutris EX; Bikiaris DN Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):49-63. PubMed ID: 19149729 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview. Patel A; Mehta T; Patel J; Patel M; Patel K; Patel N Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):66-72. PubMed ID: 22191697 [TBL] [Abstract][Full Text] [Related]
8. Site specific chronotherapeutic drug delivery systems: a patent review. Saigal N; Baboota S; Ahuja A; Ali J Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):64-70. PubMed ID: 19149730 [TBL] [Abstract][Full Text] [Related]
10. An insight to osmotic drug delivery. Sareen R; Jain N; Kumar D Curr Drug Deliv; 2012 May; 9(3):285-96. PubMed ID: 22452403 [TBL] [Abstract][Full Text] [Related]
11. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System. Li Z; He X Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200 [TBL] [Abstract][Full Text] [Related]
12. Osmotically controlled oral drug delivery. Verma RK; Mishra B; Garg S Drug Dev Ind Pharm; 2000 Jul; 26(7):695-708. PubMed ID: 10872087 [TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes. Silva AC; Santos D; Ferreira D; Lopes CM Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821 [TBL] [Abstract][Full Text] [Related]
14. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Awasthi R; Kulkarni GT Drug Deliv; 2016; 23(2):378-94. PubMed ID: 25026414 [TBL] [Abstract][Full Text] [Related]
15. Permeation enhancer strategies in transdermal drug delivery. Marwah H; Garg T; Goyal AK; Rath G Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687 [TBL] [Abstract][Full Text] [Related]
16. Oral osmotically driven systems: 30 years of development and clinical use. Malaterre V; Ogorka J; Loggia N; Gurny R Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438 [TBL] [Abstract][Full Text] [Related]
17. Oral controlled release dosage forms: dissolution versus diffusion. Bermejo M; Sanchez-Dengra B; Gonzalez-Alvarez M; Gonzalez-Alvarez I Expert Opin Drug Deliv; 2020 Jun; 17(6):791-803. PubMed ID: 32248713 [TBL] [Abstract][Full Text] [Related]
18. Drug dissolution: significance of physicochemical properties and physiological conditions. Jambhekar SS; Breen PJ Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023 [TBL] [Abstract][Full Text] [Related]
19. Diverse approaches for the enhancement of oral drug bioavailability. Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical approaches to colon targeted drug delivery systems. Chourasia MK; Jain SK J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]